Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: Analysis of 44 cases

National Medical Journal of China

Volumn 88, Issue 30, 2008, Pages 2127-2130

  Chen, Huan ^a   Liu, Kai Yan ^a   Liu, Dai Hong ^a   Xu, Lan Ping ^a   Han, Wei ^a   Chen, Yu Hong ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Mecophenolet mofetil

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIAGNOSTIC PROCEDURE; DONOR; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTERSTITIAL PNEUMONIA; LEUKEMIA; MALE; MYELODYSPLASTIC SYNDROME; PRIMARY HEALTH CARE; PROPHYLAXIS; SALVAGE THERAPY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 54949108600     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant, 1996, 10:77-84.
2. Fulton B, Markham a. Myecophenolate mofetil, a review of its pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs, 1996, 51:278-298.
3. Osunkwo I, Bessmertny O, Harrion L, et al. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogenic stem cell transplant recipients. Biol Blood Marrow Transplant, 2004, 10:246-258.
4. Basara N, Blau WI, Romer E, et al. Mycophenolate Mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients. Bone Marrow Transplant, 1998, 22:61-65.
5. Huang XJ, Liu DH, Liu KY, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant, 2006, 38:291-297.
6. Sullivan KM. Graft-versus-host disease//Blume KG, Forruan SJ, Appelbaum FR. Thomas' Hematopoietic Cell Transplantation. Blackwell Publishing, 2004:635-664.
7. Filipovicb AH, Wweisdorf D, Pavletic S, et al. National Institute of Health Consensus Development Project on Criteria for Clinical trials in chronic Graft-versus-Host Disease: I. Diagnosis and Staging working Group Report. Biol Blood Marrow Transplant, 2005, 11: 945-955.
8. Bolanos-Meade J. Update on the management of acute graft-versus-host disease. Curr Opin Oncol, 2006, 18:120-125.
9. Gaziev D, Lucarelli G. Novel approach to the treatment of chronic graft-versus-host disease. Expert Opin Investig Drug, 2001, 10: 909-923.
10. Yu C, Seidel K, Nash RA, et al. Synergism between mycophenolate mofetil and cyclosporine in preventing graft versus host disease in lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood, 1998, 91:2581-2587.
11. Chinese source.
12. Mookerjee B, Altomnte V, Vogelsang G, et al. Salvage therapy for refractory chronic graft-versus-host disease with mecophenolate mofetil and tacrolimus. Bone marrow transplant, 1999, 24:517-520.
13. Takamin A, Mochizuki K, Okumura S, et al. Mycophenolate mofetil is effective and well tolerate in the treatment of refractory acute and chronic graft-versus-host disease. Int J Hematol, 2006, 83:80-85.
14. Lopez F, Parker P, Nademanee A, et al. Efficacy of mycophenolate mofetil in treatment of chronic graft-versus-host Disease. Biol Blood Marrow Transplant, 2005, 11:307-313.
15. Baudard M, Vincent A, moreau P, et al. Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerate but induces a high risk infection complication: a series of 21 BM and PBSC transplant patients. Bone Marrow Transplant, 2002, 30:287-295.